脊髓切除术患者的COVID-19疫苗接种对免疫性血栓塞维症患者的保护作用
Xiang Liu1, Xinai Gan1,2, Jing Xu1
1Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.
British journal of haematology
|April 18, 2024
概括
接种COVID-19疫苗显著保护了脊髓切除术后患有免疫血栓塞缩症 (ITP) 的患者. 在疫情期间,接种疫苗的个人经历了严重感染,住院和ITP恶化的减少.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 传染性疾病 传染性疾病
背景情况:
- 脊髓切除术是免疫性血小板缺血 (ITP) 的公认治疗方法.
- 接种COVID-19疫苗对ITP患者脊髓切除术后的影响仍未得到充分研究,特别是在大流行期间.
研究的目的:
- 为了评估COVID-19疫苗接种在ITP的脊髓切除患者的临床结果.
- 评估疫苗接种对严重的COVID-19结果和ITP恶化的保护作用.
主要方法:
- 一项纵向研究涉及191名脊髓切除的ITP患者.
- 在COVID-19感染期间对已接种疫苗和未接种疫苗的患者进行临床结果分析,包括严重感染,住院和ITP恶化.
主要成果:
- 在76.4%的患者中,观察到脊髓切除术的持续反应.
- 接种疫苗的患者在COVID-19感染期间,严重感染 (OR 0.13),住院 (OR 0.13) 和ITP恶化 (OR 0.16) 的风险显著降低.
结论:
- 接种COVID-19疫苗在脊髓切除术ITP患者中表现出保护作用.
- 建议接种疫苗以减轻这种脆弱人群的严重后果和疾病爆发.
更多相关视频
08:04A Mouse Model of Vascularized Heterotopic Spleen Transplantation for Studying Spleen Cell Biology and Transplant Immunity
Published on: June 11, 2019
15.8K
04:00Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
Published on: November 15, 2024
166
相关概念视频
Blood Transfusion and Agglutination
10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K
Vaccinations
44.4K
Overview
44.4K
Disorders of Hemostasis
881
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
881
Bone Marrow Sampling and Transplants
327
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
327
